Iovance Biotherapeutics, Inc. (IOVA)
3.96
-0.11
(-2.70%)
USD |
NASDAQ |
Mar 13, 16:00
4.04
+0.08
(+2.02%)
After-Hours: 04:10
Iovance Biotherapeutics Profit Margin (Quarterly) : -82.92% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Orthofix Medical, Inc. | -1.01% |
| InfuSystem Holdings, Inc. | 5.62% |
| Axogen, Inc. | -21.96% |
| KalVista Pharmaceuticals, Inc. | -361.4% |
| Lantheus Holdings, Inc. | 13.30% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -54.64% |
| Return on Assets | -42.47% |
| Return on Invested Capital | -50.85% |
| Gross Profit Margin (Quarterly) | 39.31% |
| Operating Margin (Quarterly) | -84.79% |
| Return on Net Operating Assets | -67.41% |